Clinical Trial: Study of Renal Blood Flow During Human Endotoxemia
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Renal Plasma Flow During Experimental Human Endotoxemia
Brief Summary: The purpose of the present protocol is to study whether endotoxemia will affect the renal blood flow in type 2 diabetics and healthy volunteers.
Detailed Summary: Many septic patients develop acute renal failure and the risk is higher in patients with diabetes. The pathogenetic mechanisms behind the development of acute renal failure in connection with sepsis is not completely understood. One among many possible explanations is a change in renal hemodynamics. However, it is still largely unknown what happens to the renal plasma flow during human sepsis. In this study we give endotoxin injection (0,3 ng/kg) to type 2 diabetics and healthy controls as an experimental model of sepsis. Renal plasma flow and glomerular filtration rate are measured by DTPA-renography 1 day before before and 1,25 and 6,5 hours after injection of endotoxin. Furthermore WBC, plasma-cytokines,VCAM-1/ICAM-1, endothelin-1, Thromboxane B2, angiotensin 2, renin and PAI-1 are measured on an hourly basis up to 8 hours after endotoxin injection.
Sponsor: Rigshospitalet, Denmark
Current Primary Outcome: Renal plasma flow, Glomerular filtration rate, Plasma cytokine content, Endotoxemia score, Plasma angiotensin II and renin content, Plasma thromboxane B2 content, Plasma PAI-1 content
Original Primary Outcome: Same as current
Current Secondary Outcome: Mean arterial pressure, Heart rate, Oxygen saturation, Body temperature,
Original Secondary Outcome: Same as current
Information By: Rigshospitalet, Denmark
Dates:
Date Received: December 18, 2006
Date Started: November 2006
Date Completion: December 2007
Last Updated: December 18, 2006
Last Verified: December 2006